Macrogenics INC Form 4 insider transactions

Director Meenu Chhabra reports acquisition and disposal of Macrogenics Inc. stock and derivative securities.

Director Jay Philip Siegel reports acquisition and disposal of Macrogenics Inc. stock and derivative securities.

Ezio Bonvini, Sr VP, Research & CSO of Macrogenics, exercised stock options and disposed of shares on February 15, 2025.

James Karrels, SVP, CFO, and Secretary of Macrogenics Inc., reports transactions involving common stock and restricted stock units.

Macrogenics CEO Scott Koenig acquired 42,329 shares of common stock on February 15, 2025, through the vesting of restricted stock units.

Senior VP and General Counsel of Macrogenics, Jeffrey Stuart Peters, reports the vesting and disposal of restricted stock units and common stock.

Chief Operating Officer of Macrogenics, Eric Risser, reports the acquisition and disposal of common stock and restricted stock units.

Beth Ann Smith, VP, Controller & Treasurer of Macrogenics Inc, reports the vesting of restricted stock units and subsequent sale of shares on February 15, 2025.

Senior VP Thomas Spitznagel reports the vesting and disposal of Macrogenics stock and restricted stock units.

Stephen L. Eck, Chief Medical Officer of MacroGenics Inc., reports the vesting and disposal of restricted stock units and common stock transactions on February 15, 2025.

Stephen L. Eck, Chief Medical Officer of MacroGenics Inc., reports the acquisition and disposal of common stock and restricted stock units, as well as the grant of employee stock options.

Ezio Bonvini, Sr VP, Research & CSO of Macrogenics, reports exercising stock options and receiving restricted stock units, resulting in changes to his beneficial ownership of company stock.

Chief Operating Officer of Macrogenics, Eric Risser, reports exercising stock options and vesting of restricted stock units, resulting in changes to his beneficial ownership of company stock.

James Karrels, SVP, CFO, and Secretary of Macrogenics Inc., reports transactions involving common stock and derivative securities, including the vesting of restricted stock units and the grant of employee stock options.

Beth Ann Smith, VP, Controller & Treasurer of Macrogenics Inc, reports acquisition and disposal of common stock and derivative securities.

Macrogenics CEO Scott Koenig acquired 31,673 shares of common stock on February 8, 2025, through the vesting of restricted stock units (RSUs).

Thomas Spitznagel, a Senior VP at Macrogenics, reports the acquisition and disposal of common stock and derivative securities, including stock options and restricted stock units.

Jeffrey Peters, Senior VP and General Counsel of Macrogenics, reports exercising stock options and vesting of restricted stock units, resulting in changes to his beneficial ownership of company stock.

CEO Scott Koenig reports gifting shares of Macrogenics stock, with a corresponding acquisition by an irrevocable trust.

Macrogenics CEO Scott Koenig gifted 374,215 shares of common stock to The Koenig 2024 Irrevocable Trust, while retaining indirect beneficial ownership.

Margaret Liu, a director at MacroGenics Inc., filed an amended Form 4 to correct a previously reported stock option transaction.

Director Jay Philip Siegel reports acquisition of stock options and restricted stock units in Macrogenics Inc.

Director Meenu Chhabra reported the acquisition of restricted stock units and stock options in Macrogenics Inc. on May 21, 2024.

Director Federica F. O'Brien reports acquisition of stock options and restricted stock units in Macrogenics Inc.

Director Margaret Liu reports the acquisition of stock options and restricted stock units (RSUs) in Macrogenics Inc.

Director Karen Jean Ferrante reports the acquisition of stock options and restricted stock units in Macrogenics Inc.

Director David C. Stump reports acquisition of 6,500 restricted stock units and 16,500 stock options in Macrogenics Inc.

Director William K. Heiden reports acquisition of stock options and restricted stock units in Macrogenics Inc.

Director Edward Hurwitz reports acquisition of restricted stock units and stock options in Macrogenics Inc.

Director Scott Thomas Jackson of Macrogenics Inc. reports acquisition of stock options and restricted stock units.